February 10, 2017 / 2:22 PM / 6 months ago

BRIEF-Watson Pharma did not infringe Shire patents for Lialda -U.S. appeals court

Feb 10 (Reuters) - U.S. appeals court rules in favor of Watson Pharmaceuticals in patent infringement lawsuit brought by Shire related to Shire's Lialda drug -- court ruling

* Federal Circuit Court of Appeals reverses lower court ruling, and orders that a judgment of non-infringement be entered

* Shire had accused Watson of patent infringement by applying with U.S. FDA to market a generic version of Lialda, a mesalamine drug Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below